Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients

Background Hyponatremia is common in neurocritical care and is associated with poor outcome, but the optimal treatment is not known. We wished to test the hypothesis that for neurocritical care patients with severe hyponatremia (Na 

Saved in:
Bibliographic Details
Published in:Neurocritical care 2010-08, Vol.13 (1), p.57-61
Main Authors: Naidech, Andrew M., Paparello, James, Leibling, Storm M., Bassin, Sarice L., Levasseur, Kimberly, Alberts, Mark J., Bernstein, Richard A., Muro, Kenji
Format: Article
Language:English
Subjects:
Adult
Aged
Antidiuretic Hormone Receptor Antagonists
Benzazepines - administration & dosage
Benzazepines - adverse effects
Coma
Critical care
Critical Care Medicine
Critical Illness - therapy
Demographics
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug dosages
Enrollments
Female
Glasgow Coma Scale
Hemorrhage
Humans
Hyponatremia
Hyponatremia - drug therapy
Hyponatremia - physiopathology
Hypotension
Hypotheses
Injections, Intravenous
Intensive
Intensive Care Units
Internal Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Neurology
Original Article
Patients
Pilot Projects
Prospective Studies
Severity of Illness Index
Single-Blind Method
Sodium
Sodium - blood
Statistical analysis
Stroke
Surgery
Time Factors
White people
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Hyponatremia is common in neurocritical care and is associated with poor outcome, but the optimal treatment is not known. We wished to test the hypothesis that for neurocritical care patients with severe hyponatremia (Na 
ISSN:1541-6933
1556-0961
DOI:10.1007/s12028-010-9379-5